Glucose-responsive, antioxidative HA-PBA-FA/EN106 hydrogel enhanced diabetic wound healing through modulation of FEM1b-FNIP1 axis and promoting angiogenesis

Wenqian Zhang,Kangkang Zha,Yuan Xiong,Weixian Hu,Lang Chen,Ze Lin,Chenyan Yu,Wu Zhou,Faqi Cao,Hankun Hu,Bobin Mi,Guohui Liu
DOI: https://doi.org/10.1016/j.bioactmat.2023.07.006
IF: 18.9
2023-07-26
Bioactive Materials
Abstract:Highlights • FNIP1 was proved to participate in antioxidant defenses of HUVECs and diabetic wound healing. • The HA-PBA-FA/EN106 hydrogel glucose responsive released of EN106 to regulate FEM1b-FNIP1 axis and ameliorate oxidative stress. • HA-PBA-FA/EN106 hydrogel ameliorated inflammation and enhanced angiogenesis by modulating macrophage polarization. The diabetic wounds remain to be unsettled clinically, with chronic wounds characterized by drug-resistant bacterial infections, compromised angiogenesis and oxidative damage to the microenvironment. To ameliorate oxidative stress and applying antioxidant treatment in the wound site, we explore the function of folliculin-interacting protein 1 (FNIP1), a mitochondrial gatekeeper protein works to alter mitochondrial morphology, reduce oxidative phosphorylation and protect cells from unwarranted ROS accumulation. And our in vitro experiments showed the effects of FNIP1 in ameliorating oxidative stress and rescued impaired angiogenesis of HUVECs in high glucose environment. To realize the drug delivery and local regulation of FNIP1 in diabetic wound sites, a novel designed glucose-responsive HA-PBA-FA/EN106 hydrogel is introduced for improving diabetic wound healing. Due to the dynamic phenylboronate ester structure with a phenylboronic acid group between hyaluronic acid (HA) and phenylboronic acid (PBA), the hydrogel is able to realize a glucose-responsive release of drugs. Fulvic acid (FA) is added in the hydrogel, which not only severs as crosslinking agent but also provides antibacterial and anti-inflammatory abilities. Moreover, the release of FEM1b-FNIP1 axis inhibitor EN106 ameliorated oxidative stress and stimulated angiogenesis through FEM1b-FNIP1 axis regulation. These in vivo and in vitro results demonstrated that accelerated diabetic wounds repair with the use of the HA-PBA-FA/EN106 hydrogel, which may provide a promising strategy for chronic diabetic wound repair. Graphical abstract Schematic diagram of preparation and application of HA-PBA-FA/EN106 hydrogel . The schematic diagram of glucose-responsive HA-PBA-FA/EN106 hydrogel and its application in diabetic wound healing. The dynamic phenylboronate ester structure between HA and PBA makes the hydrogel glucose responsive ability. The FA provides antibacterial and anti-inflammatory abilities while EN106 regulates FEM1b-FNIP1 axis to reduce mtROS. The HA-PBA-FA/EN106 hydrogel simulated long-lasting angiogenesis and the accelerated epithelization efficiently, thus promising for a potential diabetic wound healing dress. Download : Download high-res image (253KB) Download : Download full-size image
engineering, biomedical,materials science, biomaterials
What problem does this paper attempt to address?